Federal Register / Vol. 87, No. 134 / Thursday, July 14, 2022 / Notices 42199 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID 2022 DMID Omnibus 

BAA (HHS–NIH–NIAID–BAA2022–1) 

Research Area 001: Development of Vaccine 

Candidates for Biodefense, Antimicrobial 

Resistant (AMR) Infections and Emerging 

Infectious Diseases (N01)–2. 

Date: August 9–10, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E72A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Frank S. De Silva, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3E72A, Rockville, MD 

20852, (240) 669–5023, fdesilva@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 8, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–15070 Filed 7–13–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Antiviral 

Drug Discovery and Mechanisms of 

Resistance. 

Date: August 8, 2022. 

Time: 1:00 p.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shinako Takada, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–9448, shinako.takada@

nih.gov. 

Name of Committee: Center for Scientific 

Review; Special Emphasis Panel PAR: 20– 

181, Limited Competition National Primate 

Research Program Projects. 

Date: August 10–12, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Elaine Sierra-Rivera, Ph.D., 

Scientific Review Officer, EMNR IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6182, 

MSC 7892, Bethesda, MD 20892, 301 435– 

2514, riverase@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 8, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–15071 Filed 7–13–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting for the 

Interdepartmental Serious Mental 

Illness Coordinating Committee 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The Secretary of Health and 

Human Services announces a meeting of 

the Interdepartmental Serious Mental 

Illness Coordinating Committee 

(ISMICC). 

The meeting will provide information 

on federal efforts related to serious 

mental illness (SMI) and serious 

emotional disturbance (SED). 

DATES: October 28, 2022, 10 a.m.–4:30 

p.m. (EDT)/Open. 

ADDRESSES: The meeting will be held 

virtually and can be accessed via Zoom 

at: https://www.zoomgov.com/j/161707

5418?pwd=T3RqeHFUS1p6ZFh

OVUpaSFdQRno3UT09, or by dialing 

669–254–5252, webinar ID: 161 707 

5418, passcode: 151059. Agenda with 

call-in information will be posted on the 

SAMHSA website prior to the meeting 

at: https://www.samhsa.gov/about-us/ 

advisory-councils/meetings. 

FOR FURTHER INFORMATION CONTACT: 

Pamela Foote, ISMICC Designated 

Federal Officer, SAMHSA, 5600 Fishers 

Lane, 14E53C, Rockville, MD 20857; 

telephone: 240–276–1279; email: 

pamela.foote@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background and Authority 

The ISMICC was established on 

March 15, 2017, in accordance with 

section 6031 of the 21st Century Cures 

Act, and the Federal Advisory 

Committee Act, 5 U.S.C. App., as 

amended, to report to the Secretary, 

Congress, and any other relevant federal 

department or agency on advances in 

SMI and SED, research related to the 

prevention of, diagnosis of, intervention 

in, and treatment and recovery of SMIs, 

SEDs, and advances in access to services 

and supports for adults with SMI or 

children with SED. In addition, the 

ISMICC will evaluate the effect federal 

programs related to SMI and SED have 

on public health, including public 

health outcomes such as: (A) rates of 

suicide, suicide attempts, incidence and 

prevalence of SMIs, SEDs, and 

substance use disorders, overdose, 

overdose deaths, emergency 

hospitalizations, emergency room 

boarding, preventable emergency room 

visits, interaction with the criminal 

justice system, homelessness, and 

unemployment; (B) increased rates of 

employment and enrollment in 

educational and vocational programs; 

(C) quality of mental and substance use 

disorders treatment services; or (D) any 

other criteria determined by the 

Secretary. Finally, the ISMICC will 

make specific recommendations for 

actions that agencies can take to better 

coordinate the administration of mental 

health services for adults with SMI or 

children with SED. Not later than one 

(1) year after the date of enactment of 

the 21st Century Cures Act, and five (5) 

years after such date of enactment, the 

ISMICC shall submit a report to 

Congress and any other relevant federal 

department or agency. 

II. Membership 

This ISMICC consists of federal 

members listed below or their 

designees, and non-federal public 

members. 

Federal Membership: Members 

include, The Secretary of Health and 

Human Services; The Assistant 


jspears on DSK121TN23PROD with NOTICES1
42200 Federal Register / Vol. 87, No. 134 / Thursday, July 14, 2022 / Notices 

Secretary for Mental Health and 

Substance Use; The Attorney General; 

The Secretary of the Department of 

Veterans Affairs; The Secretary of the 

Department of Defense; The Secretary of 

the Department of Housing and Urban 

Development; The Secretary of the 

Department of Education; The Secretary 

of the Department of Labor; The 

Administrator of the Centers for 

Medicare and Medicaid Services; and 

The Commissioner of the Social 

Security Administration. 

Non-federal Membership: Members 

include, not less than 14 non-federal 

public members appointed by the 

Secretary, representing psychologists, 

psychiatrists, social workers, peer 

support specialists, and other providers, 

patients, family of patients, law 

enforcement, the judiciary, and leading 

research, advocacy, or service 

organizations. 

The ISMICC is required to meet at 

least twice per year. 

To attend virtually, submit written or 

brief oral comments, or request special 

accommodation for persons with 

disabilities, contact Pamela Foote. 

Individuals can also register on-line at: 

https://snacregister.samhsa.gov. 

The public comment section will be 

scheduled at the conclusion of the 

meeting. Individuals interested in 

submitting a comment, must notify 

Pamela Foote on or before October 10, 

2022, via email to: Pamela.Foote@

samhsa.hhs.gov. 

Up to three minutes will be allotted 

for each approved public comment as 

time permits. Written comments 

received in advance of the meeting will 

be considered for inclusion in the 

official record of the meeting. 

Substantive meeting information and 

a roster of Committee members is 

available at the Committee’s website: 

https://www.samhsa.gov/about-us/ 

advisory-councils/ismicc. 

Dated: July 8, 2022. 

Carlos Castillo, 

Committee Management Officer. 

[FR Doc. 2022–14984 Filed 7–13–22; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF THE INTERIOR 

Fish and Wildlife Service 

[Docket No. FWS–R4–ES–2022–0089; 

FXES11130400000–223–FF04EF4000] 

Renewal of an Incidental Take Permit 

for Florida Key Deer and Other 

Protected Species on Big Pine Key and 

No Name Key, Monroe County, FL; 

Categorical Exclusion 

AGENCY: Fish and Wildlife Service, 

Interior. 

ACTION: Notice of availability; request 

for comment and information. 

SUMMARY: We, the Fish and Wildlife 

Service, announce receipt of an 

application from Monroe County 

(applicant) for a renewal of incidental 

take permit (ITP) under the Endangered 

Species Act. If granted, the expiration 

date of the existing ITP, which 

authorizes take of the Florida Key deer, 

the Lower Keys marsh rabbit, and the 

eastern indigo snake incidental to 

commercial and residential construction 

in Monroe County, Florida, would be 

extended for an additional 3 years. The 

applicant is seeking an extension of the 

ITP expiration date from June 30, 2023, 

to June 30, 2026. The application for 

renewal does not include a request to 

increase the amount of take authorized 

by the ITP or to modify the covered 

activities under the ITP and the 

associated habitat conservation plan 

(HCP). We request public comment on 

the application, which includes the 

applicant’s existing HCP and the 

Service’s preliminary determination that 

this ITP renewal qualifies as ‘‘loweffect,’’ categorically excluded, under 

the National Environmental Policy Act. 

To make this determination, we used 

our environmental action statement and 

low-effect screening form, both of which 

are also available for public review. 

DATES: We must receive your written 

comments on or before August 15, 2022. 

ADDRESSES:

Obtaining Documents: You may 

obtain copies of the documents online 

in Docket No. FWS–R4–ES–2022–0089 

at https://www.regulations.gov. 

Submitting Comments: If you wish to 

submit comments on any of the 

documents, you may do so in writing by 

one of the following methods: 

• Online: https://

www.regulations.gov. Follow the 

instructions for submitting comments 

on Docket No. FWS–R4–ES–2022–0089. 

• U.S. mail: Public Comments 

Processing, Attn: Docket No. FWS–R4– 

ES–2022–0089; U.S. Fish and Wildlife 

Service, MS: PRB/3W, 5275 Leesburg 

Pike, Falls Church, VA 22041–3803. 

FOR FURTHER INFORMATION CONTACT: 

Brian Powell, by telephone at (772) 469– 

4315 or via email at brian_powell@

fws.gov. Individuals in the United States 

who are deaf, deafblind, hard of hearing, 

or have a speech disability may dial 711 

(TTY, TDD, or TeleBraille) to access 

telecommunications relay services. 

Individuals outside the United States 

should use the relay services offered 

within their country to make 

international calls to the point-ofcontact in the United States. 

SUPPLEMENTARY INFORMATION: We, the 

Fish and Wildlife Service (Service), 

announce receipt of an application from 

Monroe County (applicant) for renewal 

of incidental take permit (ITP) 

TE083411–0 under the Endangered 

Species Act by extending the permit 

expiration date by 3 years. The ITP 

authorizes take of the Florida Key deer 

(Odocoileus virginianus clavium), the 

Lower Keys marsh rabbit (Sylvilagus 

palustris hefneri), and the eastern indigo 

snake (Drymarchon corais couperi), via 

destruction of these species’ feeding, 

breeding, and sheltering habitat 

incidental to commercial and residential 

construction (covered activity). The 

renewal of the ITP would not change the 

amount of covered area, the covered 

activity, or the amount or type of take 

or the species covered by the HCP and 

permit. The applicant’s mitigation for 

the incidental take of the species also 

would not change. 

The requested extension will allow 

the term of the ITP to match the 

County’s Rate of Growth Ordinance 

(ROGO) timeframe (i.e., the timeframe 

for the County to issue building permits 

for new houses commensurate with the 

ability to safely evacuate the population 

in the event of a major storm). On 

January 22, 2020, the Monroe County 

Board of County Commissioners (BOCC) 

extended the timeframe for issuing the 

remaining building permits to match the 

ROGO for an additional 3 years, from 

2023 to 2026, to provide the County 

additional time to distribute ROGO 

allocations while the new hurricane 

evacuation model is run. The extension 

also would allow the County to 

implement other strategies to help 

transition land into public ownership, 

reducing the potential for fifth 

amendment takings claims and 

addressing the overall future build-out 

of the Florida Keys. 

We request public comment on the 

application, which includes the 

applicant’s HCP and the Service’s 

preliminary determination that renewal 

of the ITP qualifies as ‘‘low-effect,’’ 

categorically excluded, under the 

National Environmental Policy Act 


jspears on DSK121TN23PROD with NOTICES1